Triazole compounds that modualte HSP90 activity
US9120745B2 · kind B2 · utility
5Cited by
2References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 23, 2014 |
| Grant date | Sep 1, 2015 |
| Priority date | — |
| Expiry date | May 23, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/65586
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for preventing or treating hyperproliferative disorders, such as cancer, in a subject in need thereof comprising administering to the subject a substituted triazole compound of the invention, or a composition comprising such a compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.